Behavioral desensitization of phobic anxiety using thiopental sodium
Abstract
The author evaluated a random sample of 25 patients suffering from a variety of phobic anxiety states who were treated with desensitization using thiopental sodium combined with progressive reduction in the use of oral anxiolytic medication. At 24-week follow-up, 11 of the patients reported mild symptoms of phobic anxiety and 14 reported none; 9 of the patients reported their use of tranquilizers had decreased and 15 reported they had used non for at least 2 weeks. These results demonstrate the usefulness of the treatment in producing sustained reduction of phobic anxiety and tranquilizer use.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
